Biochemie-Projekt Pospiech (bis 2023)

Publikationen

2024

  • Compromised CDK12 activity causes dependency on the high activity of O-GlcNAc transferase.
    Pallasaho S, Gondane A, Kutz J, Liang J, Yalala S, Duveau DY, Pospiech H, Thomas CJ, Loda M, Itkonen HM
    Glycobiology 2024 (epub ahead of print)

2023

  • Targeting cellular pathways in hyper- and ultramutated cancer cells with exonuclease-defective DNA polymerase epsilon
    Borges G
    Dissertation 2023, Jena, Germany
  • ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways-lessons from breast cancer patients.
    Sachsenweger J, Jansche R, Merk T, Heitmeir B, Deniz M, Faust U, Roggia C, Tzschach A, Schroeder C, Riess A, Pospiech H, Peltoketo H, Pylkäs K, Winqvist R, Wiesmüller L
    Cell Death Dis 2023, 14(5), 328

2022

  • Partial Reduction in BRCA1 Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or Resistance.
    Classen S, Rahlf E, Jungwirth J, Albers N, Hebestreit LP, Zielinski A, Poole L, Groth M, Koch P, Liehr T, Kankel S, Cordes N, Petersen C, Rothkamm K, Pospiech** H, Borgmann** K
    Int J Mol Sci 2022, 23(21) ** co-corresponding authors
  • Charakterisierung des potentiellen DNA-Replikationsfaktors PN70
    Kutz J
    Dissertation 2022, Jena, Germany